References
- Melby M K, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update 2005; 11: 495–512
- Freeman E W, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007; 10: 197–214
- Gold E B, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health across the Nation. Am J Public Health 2006; 96: 1226–35
- Melby M. Vasomotor symptom prevalence and language of menopause in Japan. Menopause 2005; 12: 250–7
- Malacara J M, Canto de T Cetina, Bassol S, et al. Symptoms at pre- and postmenopause in rural and urban women from three States of Mexico. Maturitas 2002; 43: 11–19
- Davis S R, Knight S, White V, et al. Climacteric symptoms among indigenous Australian women and a model for the use of culturally relevant art in health promotion. Menopause 2003; 10: 345–51
- Lawton B, Reid P, Cormack D, et al. Maori women and the menopause. Pacific Health Dialog 2001; 8: 163–5
- Statistics New Zealand. 2001 Census of population and dwellings; national summary. Statistics New Zealand, Wellington 2002
- Ajwani S, Blakely T, Robson B, et al. Decades of disparity: ethnic mortality trends in New Zealand 1980–1999, Ministry of Health. Ministry of Health, Wellington 2003
- Bramley D, Hebert P, Tuzzio L, et al. Disparities in indigenous health: a cross-country comparison between New Zealand and the United States. Am J Public Health 2005; 95: 844–50
- Harris R, Tobias M, Jeffreys M, et al. Effects of self-reported racial discrimination and deprivation on Maori health and inequalities in New Zealand: cross-sectional study. Lancet 2006; 367: 2005–9
- Rose S, Lawton B, Dowell T, et al. Risk factors for type 2 diabetes in postmenopausal women: a cross-sectional study. NZ Med J 2004; 117: U1206
- Vickers M. The MRC Long-term randomised control trial of hormone replacement therapy: background, design and objectives. J Br Menopause Soc 1996; 1: 9–13
- Vickers M R, MacLennan A H, Lawton B, et al. Main morbidities recorded in the Women's International Study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 2007; 335: 239
- Lawton B, Rose S, Dowell T. Cessation of the WHI and WISDOM trials: a New Zealand perspective. Climacteric 2002; 5: 326–8
- Salmond C, Crampton P. NZDep2001 Index of Deprivation. Wellington School of Medicine and Health Sciences. 2002, In DoP Health editor
- Rodstrom K, Bengtsson C, Lissner L, et al. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002; 9: 156–61
- Porter M, Penney G C, Russell D, et al. A population based survey of women's experience of the menopause. Br J Obstet Gynaecol 1996; 103: 1025–8
- North F, Sharples K. Changes in the use of hormone replacement therapy in New Zealand from 1991–1997. N Z Med J 2001; 114: 250–3
- Bilgrami I, Blower K, Feng J, et al. Changes in the use of hormone replacement therapy in New Zealand following the publication of the Women's Health Initiative trial. N Z Med J 2004; 117: U1175